SS
ATEX icon

Steve Schonfeld’s Anterix ATEX Stock Holding History

Steve Schonfeld’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,211
Closed -$886K – 2599
2026
Q1 		$886K Sell
23,211
-26,251
-53% -$831K 0.01% 1154
2025
Q4 		$1.08M Hold
49,462
– – ﹤0.01% 1100
2025
Q3 		$1.06M Sell
49,462
-216
-0.4% -$4.84K 0.01% 1333
2025
Q2 		$1.27M Buy
49,678
+22,638
+84% +$662K 0.01% 1207
2025
Q1 		$990K Buy
+27,040
New +$930K 0.01% 1303
2022
Q2 		– Sell
-96,906
Closed -$5.61M – 2518
2022
Q1 		$5.61M Buy
96,906
+2,454
+3% +$134K 0.05% 412
2021
Q4 		$5.55M Buy
94,452
+8,094
+9% +$491K 0.05% 434
2021
Q3 		$5.24M Buy
86,358
+13,510
+19% +$792K 0.05% 418
2021
Q2 		$4.37M Sell
72,848
-96,020
-57% -$4.81M 0.05% 495
2021
Q1 		$7.96M Buy
168,868
+128,402
+317% +$5.28M 0.1% 287
2020
Q4 		$1.52M Sell
40,466
-130,000
-76% -$4.28M 0.02% 680
2020
Q3 		$5.58M Hold
170,466
– – 0.11% 261
2020
Q2 		$7.73M Buy
+170,466
New +$8.71M 0.2% 146

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Steve Schonfeld's ATEX Position: Q2 2026 in Review

Steve Schonfeld sold out of Anterix (ATEX) in Q2 2026, closing a stake of 23,211 shares — an estimated $886K sold.

Steve Schonfeld first reported a position in ATEX in Q2 2020 and held it in 13 quarters. The position peaked at $7.96M in Q1 2021. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Steve Schonfeld reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 23,211 Anterix shares in Q2 2026, an estimated $886K.
  • Steve Schonfeld first reported a position in Anterix in Q2 2020 and held it in 13 quarters.
  • Steve Schonfeld's Anterix position peaked at $7.96M in Q1 2021.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.